187
Views
2
CrossRef citations to date
0
Altmetric
Articles

Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50 Hz, 70 G)

, , , , , & show all
Pages 138-145 | Received 15 Jul 2017, Accepted 03 May 2018, Published online: 30 May 2018

References

  • Akbarnejad, Z., Eskandary, H., Dini, L., et al. (2017a). Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G). Biomed. Pharmacother. 92:254–264.
  • Akbarnejad, Z., Eskandary, H., Vergallo, C., et al. (2017b). Effects of extremely low-frequency pulsed electromagnetic fields (ELF-PEMFs) on glioblastoma cells (U87). Electromagn. Biol. Med. 36:238–247.
  • Aldinucci, C., and Pessina, G. P. (1998). Electromagnetic fields enhance the release of both interferon γ and interleukin-6 by peripheral blood mononuclear cells after phytohaemagglutinin stimulation. Bioelectrochem. Bioenerg. 44:243–249.
  • Balcavage, W. X., Alvager, T., Swez, J., et al. (1996). A mechanism for action of extremely low frequency electromagnetic fields on biological systems. Biochem. Biophys. Res. Commun. 222:374–378.
  • Bell, G. B., Marino, A. A., and Chesson, A. L. (1992). Alterations in brain electrical activity caused by magnetic fields: Detecting the detection process. Electroencephalogr. Clin. Neurophysiol. 83:389–397.
  • Beroukhim, R., Getz, G., Nghiemphu, L., et al. (2007). Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc. Natl. Acad. Sci. U.S.A. 104:20007–20012.
  • Buemi, M., Marino, D., Di Pasquale, G., et al. (2001). Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field. Nephron. 87:269–273.
  • Cossarizza, A., Angioni, S., Petraglia, F., et al. (1993). Exposure to low frequency pulsed electromagnetic fields increases interleukin-1 and interleukin-6 production by human peripheral blood mononuclear cells. Exp Cell Res. 204:385–387.
  • Cossarizza, A., Monti, D., Bersani, F., et al. (1989). Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in mitogen-stimulated human lymphocytes from old subjects. FEBS Lett. 248:141–144.
  • Flipo, D., Fournier, M., Benquet, C., Roux, P., Le Boulaire, C., Pinsky, C., et al. (1998). Increased apoptosis, changes in intracellular Ca2+, and functional alterations in lymphocytes and macrophages after in vitro exposure to static magnetic field. J Toxicol Environ Health A. 54:63–76.
  • Floderus, B., Persson, T., Stenlund, C., et al. (1993). Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: A case-control study in Sweden. Cancer Causes & Control. 4:465–476.
  • Futreal, P. A., Coin, L., Marshall, M., et al. (2004). A census of human cancer genes. Nat. Rev. Cancer. 4:177–183.
  • Gurney, J. G., and Van Wijngaarden, E. (1999). Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: Review and comment. Neuro-Oncology. 1:212–220.
  • Haley, K. M., Russell, T. B., Boshkov, L., et al. (2014). Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor. J. Blood Med. 5:55–58.
  • Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685.
  • Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., et al. (2002). Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: Evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 62:3729–3735.
  • Mann, K., and Roschke, J. (1996). Effects of pulsed high-frequency electromagnetic fields on human sleep. Neuropsychobiology. 33:41–47.
  • Mastronardi, L., Farah, J. O., Puzzilli, F., and Ruggeri, A. (1998). Tamoxifen modulation of carboplatin cytotoxicity in a human U-138 glioma cell line. Clin. Neurol. Neurosurg. 100:89–93.
  • Morandi, M. A., Del Rio, J. A., Caren, R. P., and Caren, L. D. (1994). Effects of short term exposure to 60 Hz electromagnetic fields on interleukin 1 and interleukin 6 production by peritoneal exudate cells. Life Sci. 54:731–738.
  • Raylman, R. R., Clavo, A. C., and Wahl, R. L. (1996). Exposure to strong static magnetic field slows the growth of human cancer cells in vitro. Bioelectromagnetics. 17:358–363.
  • Rose, P. G., Fusco, N., Smrekar, M., et al. (2003). Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity. Gynecol. Oncol. 89:429–433.
  • Ruiz-Gomez, M. J., De La Pena, L., Prieto-Barcia, M. I., et al. (2002). Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Bioelectromagnetics. 23:578–585.
  • Saunders, R. (2005). Static magnetic fields: Animal studies. Prog. Biophys. Mol. Biol. 87:225–239.
  • Towbin, H., Staehelin, T., and Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:4350–4354.
  • Vaughn, D. J. (2000). Paclitaxel and carboplatin in bladder cancer. Eur. J. Cancer. 36:7–12.
  • Vergallo, C., Ahmadi, M., Mobasheri, H., & Dini, L. (2014). Impact of inhomogeneous static magnetic field (31.7–232.0 mT) exposure on human neuroblastoma SH-SY5Y cells during cisplatin administration. PloS one, 9(11), e113530.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.